Tapasree Roy Sarkar

1.5k total citations
25 papers, 985 citations indexed

About

Tapasree Roy Sarkar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tapasree Roy Sarkar has authored 25 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Tapasree Roy Sarkar's work include Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (3 papers). Tapasree Roy Sarkar is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Epigenetics and DNA Methylation (3 papers). Tapasree Roy Sarkar collaborates with scholars based in United States, Japan and Taiwan. Tapasree Roy Sarkar's co-authors include Sendurai A. Mani, Nathalie Sphyris, Joseph H. Taube, Steven J. Werden, Naoyuki Miura, Joseph Irudayaraj, Esta Sterneck, Jeffrey T. Chang, Shikha Sharan and Biplab Giri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioinformatics and Molecular and Cellular Biology.

In The Last Decade

Tapasree Roy Sarkar

25 papers receiving 978 citations

Peers

Tapasree Roy Sarkar
Tapasree Roy Sarkar
Citations per year, relative to Tapasree Roy Sarkar Tapasree Roy Sarkar (= 1×) peers Rafał Sądej

Countries citing papers authored by Tapasree Roy Sarkar

Since Specialization
Citations

This map shows the geographic impact of Tapasree Roy Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tapasree Roy Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tapasree Roy Sarkar more than expected).

Fields of papers citing papers by Tapasree Roy Sarkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tapasree Roy Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tapasree Roy Sarkar. The network helps show where Tapasree Roy Sarkar may publish in the future.

Co-authorship network of co-authors of Tapasree Roy Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Tapasree Roy Sarkar. A scholar is included among the top collaborators of Tapasree Roy Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tapasree Roy Sarkar. Tapasree Roy Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarkar, Mrinmoy, James Sampson, Yava Jones‐Hall, et al.. (2025). LILRB4 regulates circadian disruption-induced mammary tumorigenesis via non-canonical WNT signaling pathway. Oncogene. 44(46). 4491–4504. 1 indexed citations
2.
Sarkar, Mrinmoy, et al.. (2023). Cancer-associated fibroblasts: The chief architect in the tumor microenvironment. Frontiers in Cell and Developmental Biology. 11. 1089068–1089068. 84 indexed citations
3.
Sarkar, Mrinmoy, et al.. (2023). The Cytotoxicity of Carbon Nanotubes and Hydroxyapatite, and Graphene and Hydroxyapatite Nanocomposites against Breast Cancer Cells. Nanomaterials. 13(3). 556–556. 9 indexed citations
4.
Deo, Kaivalya A., Tanmay Mathur, Giriraj Lokhande, et al.. (2022). 2D Nanosilicate for additive manufacturing: Rheological modifier, sacrificial ink and support bath. Bioprinting. 25. e00187–e00187. 16 indexed citations
5.
Dey, Sananda, Tanushree Mondal, Subhash Haldar, et al.. (2022). Multifaceted entrancing role of glucose and its analogue, 2-deoxy-D-glucose in cancer cell proliferation, inflammation, and virus infection. Biomedicine & Pharmacotherapy. 156. 113801–113801. 37 indexed citations
6.
Sphyris, Nathalie, Steven J. Werden, Geraldine V. Vijay, et al.. (2021). Carcinoma cells that have undergone an epithelial-mesenchymal transition differentiate into endothelial cells and contribute to tumor growth. Oncotarget. 12(8). 823–844. 5 indexed citations
7.
Mallick, Bani K., et al.. (2020). Bayesian structural equation modeling in multiple omics data with application to circadian genes. Bioinformatics. 36(13). 3951–3958. 5 indexed citations
8.
Carrow, James K., Kanwar Abhay Singh, Manish K. Jaiswal, et al.. (2020). Photothermal modulation of human stem cells using light-responsive 2D nanomaterials. Proceedings of the National Academy of Sciences. 117(24). 13329–13338. 61 indexed citations
9.
Sarkar, Tapasree Roy, et al.. (2019). Multiple Omics Data Integration to Identify Long Noncoding RNA Responsible for Breast Cancer–Related Mortality. Cancer Informatics. 18. 2411618237–2411618237. 3 indexed citations
10.
Sarkar, Tapasree Roy, et al.. (2018). ATM-dependent activation of SIM2s regulates homologous recombination and epithelial–mesenchymal transition. Oncogene. 38(14). 2611–2626. 18 indexed citations
11.
Bollong, Michael J., Mika Pietilä, Tapasree Roy Sarkar, et al.. (2017). A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers. Proceedings of the National Academy of Sciences. 114(46). E9903–E9912. 57 indexed citations
12.
Taube, Joseph H., Nathalie Sphyris, Robiya Joseph, et al.. (2017). The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition. Oncotarget. 8(39). 65548–65565. 48 indexed citations
13.
Devaiah, Shivakumar P., Daniel K. Owens, Tapasree Roy Sarkar, et al.. (2016). Identification, Recombinant Expression, and Biochemical Analysis of Putative Secondary Product Glucosyltransferases from Citrus paradisi. Journal of Agricultural and Food Chemistry. 64(9). 1957–1969. 19 indexed citations
14.
Werden, Steven J., Nathalie Sphyris, Tapasree Roy Sarkar, et al.. (2016). Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Oncogene. 35(46). 5977–5988. 44 indexed citations
15.
Mitra, Shreya, Lorenzo Federico, Wei Zhao, et al.. (2016). Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT. Oncotarget. 7(26). 40252–40265. 29 indexed citations
16.
Sphyris, Nathalie, Tapasree Roy Sarkar, Venkata Lokesh Battula, Michael Andreeff, & Sendurai A. Mani. (2015). GD2 and GD3 synthase: novel drug targets for cancer therapy. Molecular & Cellular Oncology. 2(3). e975068–e975068. 4 indexed citations
17.
Sarkar, Tapasree Roy, Steven J. Werden, Geraldine V. Vijay, et al.. (2014). GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer. Oncogene. 34(23). 2958–2967. 98 indexed citations
18.
Hollier, Brett G., Agata A. Tinnirello, Steven J. Werden, et al.. (2013). FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer. Cancer Research. 73(6). 1981–1992. 220 indexed citations
19.
Wang, Jun, Tapasree Roy Sarkar, Ming Zhou, et al.. (2010). CCAAT/enhancer binding protein delta (C/EBPδ, CEBPD)-mediated nuclear import of FANCD2 by IPO4 augments cellular response to DNA damage. Proceedings of the National Academy of Sciences. 107(37). 16131–16136. 38 indexed citations
20.
Sarkar, Tapasree Roy & Joseph Irudayaraj. (2008). Carboxyl-coated magnetic nanoparticles for mRNA isolation and extraction of supercoiled plasmid DNA. Analytical Biochemistry. 379(1). 130–132. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026